VICTORIA SKOBEL: Open Payments
NPI 1770671307 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 24 payments from 13 companies in 2025. Trend: 2023 $1,454 · 2024 $1,247 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $118 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| Cleerly, Inc. | 1 | $66 |
| HEARTFLOW, INC. | 2 | $51 |
| Amgen Inc. | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Abbott Laboratories | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| BridgeBio Pharma, Inc. | 1 | $25 |
Products named: LEQVIO, ELIQUIS, Cleerly Ischemia, FFRct, VERQUVO, VYNDAQEL, JOT DX, JARDIANCE.
Industry payments across TX — which companies pay providers there.
